Monte Rosa Therapeutics logo

Monte Rosa Therapeutics

BrandBoston, MassachusettsWebsite

Company Overview

Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. Monta Rosa’s QuEENTM (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology and proteomics to identify degradable protein targets and rationally design MGDs with unprecedented selectivity. The QuEENTM discovery engine enables access to a wide-ranging and differentiated target space of well-validated biology across multiple therapeutic areas. Monte Rosa has developed the industry’s leading pipeline of MGDs.
Founded
2018
Headquarters
Boston, Massachusetts
Employees
51-200
25.8% growth last 12mo
Marketing Team
1
1% of company

Overall Headcount Trend

Overall Headcount Trend

Company growth over the last 12 months

Salaries

Community Salary Data

Help build salary transparency at Monte Rosa Therapeutics. Share your compensation anonymously.

Contribute

Reviews

Jobs